[Oxyterracine, biseptol, ampicillin and oxyterracine with biseptol in the treatment of exacerbations of chronic bronchitis].
D000667:Ampicillin / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006192:Haemophilus Infections / Q000188:drug therapy; D006193:Haemophilus influenzae; D006801:Humans; D010118:Oxytetracycline / Q000008:administration & dosage*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus; D013420:Sulfamethoxazole / Q000008:administration & dosage*; D014295:Trimethoprim / Q000008:administration & dosage*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D000667:Ampicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole; D010118:Oxytetracycline
Oksyterracyna, biseptol, ampicylina oraz oksyterracyna z biseptolem w leczeniu zaostrzeń przewlekłego zapalenia oskrzeli.